oxazoles has been researched along with Cell Transformation, Neoplastic in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (50.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, L; Chen, S; Chen, X; Du, Q; Han, W; Li, Y; Olumi, AF; Qian, X; Ruan, A; Wang, R; Wang, X; Yang, H; Zhang, X | 1 |
| Carl, PL; Chakravarty, PK; Katzenellenbogen, JA; Weber, MJ | 1 |
| Colacci, A; Grilli, S; Perocco, P | 1 |
| Fabisiak, JP; Johnson, CS; Lazo, JS; Vogt, A; Wang, AS; Wipf, P | 1 |
| Calderon, TM; Christman, JK; Michl, J; Schneiderman, N | 1 |
| Davies, AJ; Kerbel, RS | 1 |
1 review(s) available for oxazoles and Cell Transformation, Neoplastic
| Article | Year |
|---|---|
The possible biological significance of Fc receptors on mammalian lymphocytes and tumor cells.
Topics: Animals; Antibodies, Neoplasm; Antibody Formation; Antibody-Producing Cells; Antigen-Antibody Complex; Antigens, Neoplasm; B-Lymphocytes; Binding Sites, Antibody; Cell Membrane; Cell Migration Inhibition; Cell Transformation, Neoplastic; Complement System Proteins; Guinea Pigs; Haplorhini; Immune Adherence Reaction; Immune Tolerance; Immunoglobulin Fc Fragments; Immunosuppression Therapy; Lymphocytes; Macrophages; Mice; Mitosis; Neoplasms; Oxazoles; Rats; T-Lymphocytes; Time Factors | 1974 |
5 other study(ies) available for oxazoles and Cell Transformation, Neoplastic
| Article | Year |
|---|---|
Inhibition of PP2A activity confers a TRAIL-sensitive phenotype during malignant transformation.
Topics: Antigens, Polyomavirus Transforming; Apoptosis; Cell Line; Cell Transformation, Neoplastic; Dose-Response Relationship, Drug; Enzyme Inhibitors; Epithelial Cells; Gene Expression Regulation; Humans; Male; Marine Toxins; Okadaic Acid; Oxazoles; Phenotype; Protein Phosphatase 2; RNA, Small Interfering; Telomerase; TNF-Related Apoptosis-Inducing Ligand | 2014 |
Plasmin-activated prodrugs for cancer chemotherapy. 1. Synthesis and biological activity of peptidylacivicin and peptidylphenylenediamine mustard.
Topics: Animals; Antineoplastic Agents; Biotransformation; Cell Survival; Cell Transformation, Neoplastic; Female; Fibrinolysin; Isoxazoles; Melanoma; Mice; Nitrogen Mustard Compounds; Oligopeptides; Ovarian Neoplasms; Oxazoles; Plasminogen Activators | 1983 |
In vitro cytotoxic and cell transforming activities exerted by the pesticides cyanazine, dithianon, diflubenzuron, procymidone, and vinclozolin on BALB/c 3T3 cells.
Topics: 3T3 Cells; Animals; Anthraquinones; Bridged Bicyclo Compounds; Carcinogenicity Tests; Carcinogens; Cell Survival; Cell Transformation, Neoplastic; Diflubenzuron; Fungicides, Industrial; Liver Extracts; Mice; Mice, Inbred BALB C; Microsomes, Liver; Oxazoles; Transformation, Genetic; Triazines | 1993 |
In vivo antitumor activity and induction of insulin-like growth factor-1-resistant apoptosis by SC-alphaalphadelta9.
Topics: Aminobutyrates; Animals; Antineoplastic Agents; Apoptosis; Blotting, Western; Carboplatin; Cell Cycle Proteins; Cell Transformation, Neoplastic; Dose-Response Relationship, Drug; Down-Regulation; Drug Interactions; Etoposide; Inhibitory Concentration 50; Insulin-Like Growth Factor I; Interleukin-3; Mice; Oxazoles; Receptor, IGF Type 1; Time Factors; Tumor Cells, Cultured; Tumor Stem Cell Assay | 2000 |
5,5'-Dimethyloxazolidine-2,4-dione is a strong inducer of differentiation of human promyelocytic leukemia (HL-60) cells.
Topics: Animals; Cell Division; Cell Line; Cell Transformation, Neoplastic; Dimethadione; Humans; Hydrogen-Ion Concentration; Leukemia, Erythroblastic, Acute; Leukemia, Promyelocytic, Acute; Mice; Oxazoles; Tumor Cells, Cultured | 1989 |